Nivolumab activity in advanced refractory malignant peritoneal mesothelioma.

Eur J Cancer

Department of Medical Oncology, Institut Curie, PSL Research University, Paris, 75248, France; Cancer, Heterogeneity, Instability and Plasticity (CHIP), Equipe Labellisée Par La Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, INSERM U830, Paris, 75248, France. Electronic address:

Published: February 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.11.024DOI Listing

Publication Analysis

Top Keywords

nivolumab activity
4
activity advanced
4
advanced refractory
4
refractory malignant
4
malignant peritoneal
4
peritoneal mesothelioma
4
nivolumab
1
advanced
1
refractory
1
malignant
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!